X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 53 filers reported holding X4 PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365,150 | -43.8% | 335,000 | 0.0% | 0.47% | -15.9% |
| Q2 2023 | $649,900 | +123.0% | 335,000 | 0.0% | 0.56% | +131.5% |
| Q1 2023 | $291,450 | -12.4% | 335,000 | 0.0% | 0.24% | 0.0% |
| Q4 2022 | $332,655 | -41.9% | 335,000 | 0.0% | 0.24% | -29.1% |
| Q3 2022 | $573,000 | +77.4% | 335,000 | 0.0% | 0.34% | +62.7% |
| Q2 2022 | $323,000 | -44.9% | 335,000 | 0.0% | 0.21% | -27.7% |
| Q1 2022 | $586,000 | -23.6% | 335,000 | 0.0% | 0.29% | +4.0% |
| Q4 2021 | $767,000 | -56.7% | 335,000 | 0.0% | 0.28% | -45.6% |
| Q3 2021 | $1,772,000 | -18.6% | 335,000 | 0.0% | 0.51% | -8.6% |
| Q2 2021 | $2,178,000 | -24.5% | 335,000 | 0.0% | 0.56% | -16.7% |
| Q1 2021 | $2,884,000 | +33.9% | 335,000 | 0.0% | 0.67% | +34.7% |
| Q4 2020 | $2,154,000 | -5.0% | 335,000 | 0.0% | 0.50% | -45.5% |
| Q3 2020 | $2,268,000 | -27.4% | 335,000 | 0.0% | 0.91% | +2.0% |
| Q2 2020 | $3,122,000 | -6.8% | 335,000 | 0.0% | 0.90% | -10.6% |
| Q1 2020 | $3,350,000 | -6.6% | 335,000 | 0.0% | 1.00% | +28.6% |
| Q4 2019 | $3,585,000 | -1.0% | 335,000 | +17.5% | 0.78% | -28.9% |
| Q3 2019 | $3,622,000 | -15.3% | 285,000 | 0.0% | 1.10% | -4.4% |
| Q2 2019 | $4,275,000 | – | 285,000 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |